Get started
Author

D. Chang

Observed names: D.H. CHANG, D.H. Chang, David Chang, David H Chang, David H. Chang
Observed institutions: Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center, University of California, Los Angeles, Valley Hospital, St Vincent's Hospital Sydney, Stanford Medicine, Cedars-Sinai Smidt Heart Institute, Cardiovascular Medical Group, Columbia University, Rockefeller University
ORCID: 0000-0002-5361-0035
Observed ORCID: 0000-0002-5361-0035
OpenAlex ID: A5104928811
A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma
2003 · Madhav V. Dhodapkar, Matthew D. Geller, et al. · The Journal of Experimental Medicine · 425
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 · David H. Chang, Keren Osman, et al. · The Journal of Experimental Medicine · 415
PDF
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
2006 · David H. Chang, Nancy Liu, et al. · Blood · 271
Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study
2023 · Susheel Kodali, Rebecca T Hahn, et al. · European Heart Journal · 233
PDF
Predicted heart mass is the optimal metric for size match in heart transplantation
2018 · Evan P. Kransdorf, Michelle M. Kittleson, et al. · The Journal of Heart and Lung Transplantation · 233
PDF
Reduction of alloantibodies via proteosome inhibition in cardiac transplantation
2011 · Jignesh Patel, Matthew Everly, et al. · The Journal of Heart and Lung Transplantation · 151
BLIMP-1: trigger for differentiation of myeloid lineage
2000 · David H. Chang, Cristina Angelin-Duclos, et al. · Nature Immunology · 149
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
2008 · David H. Chang, Haiteng Deng, et al. · Blood · 143
Randomized Pilot Trial of Gene Expression Profiling Versus Heart Biopsy in the First Year After Heart Transplant
2015 · Jon Kobashigawa, Jignesh Patel, et al. · Circulation Heart Failure · 107
PDF
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure
2023 · Emerson C. Perin, Kenneth M. Borow, et al. · Journal of the American College of Cardiology · 88
Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients
2020 · Jignesh K. Patel, Guillaume Coutance, et al. · American Journal of Transplantation · 76
PDF
Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
2020 · David H. Chang, Jong-Chan Youn, et al. · International Journal of Heart Failure · 59
Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization
2018 · Andriana P. Nikolova, Tara C. Hitzeman, et al. · JAMA Cardiology · 51
PDF
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant
2021 · Lillian Benck, Evan P. Kransdorf, et al. · The Journal of Heart and Lung Transplantation · 50
Combined Heart and Kidney Transplantation: Clinical Experience in 100 Consecutive Patients
2019 · Morcos Atef Awad, Lawrence S. C. Czer, et al. · Journal of the American Heart Association · 43
Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound
2016 · Babak Azarbal, Richard Cheng, et al. · Circulation Heart Failure · 41
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report
2020 · Gaurang Vaidya, Lawrence S.C. Czer, et al. · Transplantation Proceedings · 39
PDF
Mechanical circulatory support for cardiac amyloidosis
2019 · Michelle M. Kittleson, Robert M. Cole, et al. · Clinical Transplantation · 38
The Effect of Lung Cancer on Cytokine Expression in Peripheral Blood Mononuclear Cells
2013 · David H. Chang, John R. Rutledge, et al. · PLoS ONE · 31
PDF
Long‐term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus‐eluting stents for the treatment of cardiac allograft vasculopathy
2016 · Richard Cheng, Christopher Vanichsarn, et al. · Catheterization and Cardiovascular Interventions · 28
Combined Heart and Kidney Transplantation: A 23-Year Experience
2017 · M. Awad, L.S.C. Czer, et al. · Transplantation Proceedings · 27
Immunosuppression Following Heart Transplantation: Prospects and Challenges
2014 · David H Chang, Michelle M Kittleson, et al. · Immunotherapy · 27
Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors
2009 · Ganepola A. P. Ganepola, Robert M. Mazziotta, et al. · Clinical & Experimental Metastasis · 26
Acceptable Post–Heart Transplant Outcomes Support Temporary MCS Prioritization in the New OPTN|UNOS Heart Allocation Policy
2020 · Heidi Reich, Danny Ramzy, et al. · Transplantation Proceedings · 23
Combined heart and kidney transplantation—Is there a protective effect against cardiac allograft vasculopathy using intravascular ultrasound?
2019 · Takuma Sato, Richard Cheng, et al. · The Journal of Heart and Lung Transplantation · 22
Works count: 242
Citation count: 3,268
H-index: 23
I10-index: 41
Year
Topic
Type